Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells. [electronic resource]
Producer: 20200325Description: 152621 p. digitalISSN:- 1618-0631
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm -- physiology
- Female
- Humans
- Protein Tyrosine Phosphatase, Non-Receptor Type 11 -- metabolism
- Up-Regulation
- Uterine Cervical Neoplasms -- enzymology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.